Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.02021-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Suyeon Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, South Korea. Hauptthemen laut MEDLINE: Colistin, Acinetobacter baumannii, Klebsiella pneumoniae, Tigecycline. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
There is a critical need for treatment strategies to combat carbapenem-resistant Gram-negative pathogens. This study investigates the efficacy of combining low concentrations of colistin with tigecycline against colistin- and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii strains. We used two strains of KPC-2-producing K. pneumoniae and OXA-23-producing A. baumannii , both of which are highly colistin-resistant. In the in vitro time-killing assays, monotherapy with colistin (2 mg/L) and tigecycline (4 or 8 mg/L) was ineffective against all strains. However, the combination of colistin (2 mg/L) and tigecycline (4 or 8 mg/L) inhibited bacterial growth. Survival analysis of Galleria mellonella larvae also demonstrated the efficacy of low concentrations of colistin and tigecycline against colistin- and carbapenem-resistant strains. All larvae survived when treated with a combination of colistin and tigecycline, whereas monotherapy with either colistin or tigecycline did not increase larval survival rates. This study proposes using a combination of tigecycline and colistin at clinical concentrations to treat carbapenem-resistant K. pneumoniae and A. baumannii, regardless of colistin resistance. IMPORTANCE Colistin resistance in carbapenem-resistant Gram-negative pathogens is a serious challenge in clinical settings. Our study showed that low concentration of colistin can be effective when combined with tigecycline. It presents the possibility of an available treatment option for antibiotic-resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, South Korea.
ORCID-Profile: Kwan Soo Ko
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Park, S., Jin, Y., & Ko, K. S. (2025). Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02021-24
Vancouver
Park S, Jin Y, Ko KS. Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02021-24
BibTeX
@article{Park2025,
author = {Park, Suyeon and Jin, Yanhong and Ko, Kwan Soo},
title = {Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.02021-24}
}
EUVIMED